Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q1 2019 13F Holders as of 31 Mar 2019
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 98,459,627
- Total 13F shares
- 58,332,415
- Share change
- +7,721,478
- Total reported value
- $4,045,800,203
- Put/Call ratio
- 36%
- Price per share
- $69.36
- Number of holders
- 170
- Value change
- +$544,963,218
- Number of buys
- 116
- Number of sells
- 46
Report period
Q1 2019
Institutions
170
Top holders
10
RARE full security history
Newer quarter: Q2 2019
Previous quarter: Q4 2018
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.1%
|
5,996,082
|
$260,710,000 | — | 31 Dec 2018 | |
| Capital Research Global Investors |
13F
|
Company |
5.9%
|
5,856,155
|
$254,626,000 | — | 31 Dec 2018 | |
| Capital International Investors |
13F
|
Company |
4.7%
|
4,589,854
|
$199,567,000 | — | 31 Dec 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
4,476,812
|
$194,652,000 | — | 31 Dec 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
4,161,780
|
$180,954,000 | — | 31 Dec 2018 | |
| FMR LLC |
13F
|
Company |
3%
|
2,946,924
|
$128,133,000 | — | 31 Dec 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
2,730,381
|
$118,717,000 | — | 31 Dec 2018 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,051,639
|
$89,205,000 | — | 31 Dec 2018 | |
| Capital World Investors |
13F
|
Company |
1.6%
|
1,583,390
|
$68,846,000 | — | 31 Dec 2018 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.5%
|
1,471,934
|
$64,000,000 | — | 31 Dec 2018 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.3%
|
1,277,319
|
$55,538,000 | — | 31 Dec 2018 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1%
|
1,010,036
|
$43,916,000 | — | 31 Dec 2018 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1%
|
1,008,223
|
$43,838,000 | — | 31 Dec 2018 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.92%
|
902,103
|
$39,223,000 | — | 31 Dec 2018 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.86%
|
846,472
|
$36,806,000 | — | 31 Dec 2018 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.83%
|
819,526
|
$35,633,000 | — | 31 Dec 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.59%
|
580,580
|
$25,243,000 | — | 31 Dec 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
568,230
|
$24,706,000 | — | 31 Dec 2018 | |
| CAPITAL GUARDIAN TRUST CO |
13F
|
Company |
0.47%
|
460,852
|
$20,038,000 | — | 31 Dec 2018 | |
| HIGHLINE CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.47%
|
458,513
|
$19,936,000 | — | 31 Dec 2018 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.43%
|
425,000
|
$18,479,000 | — | 31 Dec 2018 | |
| NORGES BANK |
13F
|
Company |
0.37%
|
369,078
|
$16,047,000 | — | 31 Dec 2018 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.36%
|
356,202
|
$15,487,000 | — | 31 Dec 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.33%
|
321,834
|
$13,993,000 | — | 31 Dec 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.31%
|
300,867
|
$13,081,000 | — | 31 Dec 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
261,611
|
$11,375,000 | — | 31 Dec 2018 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.24%
|
238,828
|
$10,384,000 | — | 31 Dec 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
207,916
|
$9,040,000 | — | 31 Dec 2018 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
199,515
|
$8,675,000 | — | 31 Dec 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
186,874
|
$8,124,000 | — | 31 Dec 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.19%
|
184,516
|
$8,023,000 | — | 31 Dec 2018 | |
| AXA S.A. |
13F
|
Company |
0.18%
|
176,025
|
$7,654,000 | — | 31 Dec 2018 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.18%
|
173,700
|
$7,552,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
149,814
|
$6,514,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
147,238
|
$6,402,000 | — | 31 Dec 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.14%
|
136,555
|
$5,936,000 | — | 31 Dec 2018 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.13%
|
132,466
|
$5,760,000 | — | 31 Dec 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.13%
|
130,794
|
$5,687,000 | — | 31 Dec 2018 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
126,278
|
$5,491,000 | — | 31 Dec 2018 | |
| Capital Bank & Trust Co |
13F
|
Company |
0.12%
|
120,307
|
$5,231,000 | — | 31 Dec 2018 | |
| S.c.a. Candriam |
13F
|
Individual |
0.12%
|
115,500
|
$5,022,000 | — | 31 Dec 2018 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.1%
|
100,000
|
$4,348,000 | — | 31 Dec 2018 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.09%
|
87,710
|
$3,678,074 | — | 31 Dec 2018 | |
| Swiss National Bank |
13F
|
Company |
0.09%
|
84,252
|
$3,663,000 | — | 31 Dec 2018 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.08%
|
76,958
|
$3,346,000 | — | 31 Dec 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
74,783
|
$3,252,000 | — | 31 Dec 2018 | |
| Capital International Sarl |
13F
|
Company |
0.07%
|
71,100
|
$3,091,000 | — | 31 Dec 2018 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
65,561
|
$2,851,000 | — | 31 Dec 2018 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.07%
|
64,000
|
$2,783,000 | — | 31 Dec 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
63,105
|
$2,744,000 | — | 31 Dec 2018 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2019
As of 31 Mar 2019,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,332,415 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, Capital International Investors, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, FIRST TRUST ADVISORS LP, and Capital World Investors.
This page lists
170
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
155
Q1 2019 holders
170
Holder diff
15
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.